High Ingredient Prices Increase Supply Chain Risks – FDA Compliance Exec
This article was originally published in The Tan Sheet
Executive Summary
Rising ingredient prices should raise red flags for dietary supplement firms that lack supply chain oversight, FDA compliance official Deborah Autor said
You may also be interested in...
Senate Food Safety Bill Continues Congressional Quest To Expand FDA Powers
Senate legislation to reform FDA food safety enforcement has garnered bipartisan and industry support since its introduction July 31, with proposals to boost the agency's authority in the wake of recent concerns about imports and a salmonella outbreak linked to produce
FDA Adds $24.2 Million To Unapproved Drug Initiative Scorecard
Two weeks after FDA officials attempted to explain how well the Center for Drug Evaluation and Research's unapproved drug initiative is working, the agency showed how actions often speak louder than words
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.